Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Catherine L. Munera"'
Autor:
Megan J. Shram, Robert H. Spencer, Jenny Qian, Catherine L. Munera, Michael E. Lewis, Jack E. Henningfield, Lynn Webster, Frédérique Menzaghi
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 2, Pp 535-547 (2022)
Abstract Difelikefalin, a selective kappa‐opioid receptor agonist with limited central nervous system penetration, is being developed for the treatment of chronic pruritic conditions. This randomized, double‐blind, active‐ and placebo‐control
Externí odkaz:
https://doaj.org/article/60ec05c898d44489a5a58573d586842c
Autor:
Eugene R. Viscusi, Marc C. Torjman, Catherine L. Munera, Joseph W. Stauffer, Beatrice S. Setnik, Sukirti N. Bagal
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 5, Pp 1886-1893 (2021)
Abstract Difelikefalin, a selective kappa opioid receptor agonist designed to limit central nervous system (CNS) penetration, is under development for the treatment of pruritus. Its hydrophilic, small‐peptidic structure limits CNS entry, minimizing
Externí odkaz:
https://doaj.org/article/3b982fee4bb049f88ec64eac8405037b
Autor:
Donald C. Simonson, Peter Johnston, Harold E. Lebovitz, Philip Raskin, Robert F Coniff, Catherine L. Munera
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 83:1515-1522
The objective of this study was to determine the safety, efficacy, and tolerability of the alpha-glucosidase inhibitor miglitol vs. the sulfonylurea glyburide in the treatment of elderly patients with type 2 diabetes mellitus, inadequately controlled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdc30161f47ee44354fc51eb46dd9bde
https://doi.org/10.1210/jcem.83.5.4824
https://doi.org/10.1210/jcem.83.5.4824